ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1248

A Retrospective Chart Review Examining How a Change in MRI Protocol Could Affect the Diagnosis of Axial Spondyloarthritis

Alexa Kouroukis1, Manisha Mulgund2, Leilani Famorca3, Pauline Boulos1 and Viktoria Pavlova4, 1McMaster University, Hamilton, ON, Canada, 2Trillium Health Partners, Ancaster, ON, Canada, 3McMaster University, Milton, ON, Canada, 4McMaster University, Ancaster, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Diagnostic criteria, Magnetic resonance imaging (MRI), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: St. Joseph’s Healthcare Hamilton (SJHH) recently changed their MRI-axial spondyloarthritis (axSpA) protocol, used to diagnose patients with axSpA, from an MRI of the spine and sacroiliac joints (SI) to an MRI of only the SI joints. The aim of this study is to determine if the accuracy of diagnosing axSpA will be reduced with this new limited MRI protocol, as well as to see if there are any characteristics that differentiate patients with sacroiliitis ± spondylitis compared to those with spondylitis alone.

Methods: This was a retrospective chart review. Using electronic medical records from four community rheumatologists in Southwestern Ontario, a computerized search was performed using the diagnostic code 720 to identify eligible patients. All patients newly diagnosed with axSpA or ankylosing spondylitis (AS) between January 2011 to January 2021 who had an MRI-axSpA protocol performed at SJHH were included. Their MRI reports were reviewed to determine how many of these patients had sacroiliitis ± spondylitis versus spondylitis alone. Patient characteristics were also extracted, including age, sex, duration of symptoms, measures of disease activity, and laboratory markers. Continuous variables were analyzed using a t-test and categorical variables were analyzed using Pearson’s chi-squared test.

Results: 275 patients were identified, of which 86 patients fulfilled criteria and were included in the study. Baseline characteristics of this entire cohort were mean age of 42, equal numbers of men and women, mean duration of back pain of 9 years, 56% HLA-B27+, mean CRP of 9.62 mg/L, and mean BASDAI score of 5.7. Analysis showed 82 patients had sacroiliitis ± spondylitis and 4 had spondylitis alone. The change in MRI protocol would be 95% accurate in diagnosing axSpA in this cohort of patients. Unfortunately, there were no statistically significant differences in the characteristics analyzed between groups (See Table 1).

Table 1. Patient demographics stratified by MRI findings

Patients (n=86)
Sacroiliitis ± spondylitis (n=82) Spondylitis alone (n=4) p-value
Age (years) 42 ± 14.2 54 ± 7.6 0.075
Female – no. (%) 40 (49) 3 (75) 0.306
Mean duration of back pain (years) 8.93 ± 10.7 10.1 ± 14.0 0.902
HLAB27+ – no. (%) 45 (55) 3 (75) 0.670
CRP (mg/L) 9.71 ± 19.0 9.80 ± 10.4 0.984
BASDAI 5.70 ± 2.0 6.97 ± 0.6 0.248

Conclusion: In this population, the updated protocol would save time and money while continuing to effectively diagnose patients with axSpA 95% of the time. Clinicians should be aware that although most patients with axSpA will be identified by an MRI of the SI joints alone, a small proportion of patients could be missed. Clinically it appears that patients who are older, female, and/or HLA-B27+ may be more likely to have spondylitis alone, however there were no statistical differences in our measurements, likely related to the small sample size of this group. Next steps would be to expand this study to include a larger cohort of patients in order to make more robust conclusions.


Disclosures: A. Kouroukis, None; M. Mulgund, None; L. Famorca, None; P. Boulos, None; V. Pavlova, None.

To cite this abstract in AMA style:

Kouroukis A, Mulgund M, Famorca L, Boulos P, Pavlova V. A Retrospective Chart Review Examining How a Change in MRI Protocol Could Affect the Diagnosis of Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/a-retrospective-chart-review-examining-how-a-change-in-mri-protocol-could-affect-the-diagnosis-of-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-retrospective-chart-review-examining-how-a-change-in-mri-protocol-could-affect-the-diagnosis-of-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology